Assessment of cardiovascular disease risk: a 2022 update
E Goldsborough, N Osuji… - … and Metabolism Clinics, 2022 - endo.theclinics.com
Cardiovascular diseases (CVDs) are the leading cause of death worldwide, with
atherosclerotic cardiovascular disease (ASCVD) being the dominant cause of total CVD …
atherosclerotic cardiovascular disease (ASCVD) being the dominant cause of total CVD …
Cardiovascular risk stratification by coronary computed tomography angiography imaging: current state-of-the-art
AS Antonopoulos, A Angelopoulos… - European journal of …, 2022 - academic.oup.com
Current cardiovascular risk stratification by use of clinical risk score systems or plasma
biomarkers is good but less than satisfactory in identifying patients at residual risk for …
biomarkers is good but less than satisfactory in identifying patients at residual risk for …
[HTML][HTML] Life's essential 8 and life's simple 7 in relation to coronary Atherosclerosis: results from the population-based SCAPIS project
Á Herraiz-Adillo, S Higueras-Fresnillo, VH Ahlqvist… - Mayo Clinic …, 2024 - Elsevier
Objective To examine the associations between the American Heart Association scores
(“Life's Essential 8”[LE8] and “Life's Simple 7”[LS7]) and 2 subclinical coronary …
(“Life's Essential 8”[LE8] and “Life's Simple 7”[LS7]) and 2 subclinical coronary …
Physical fitness in male adolescents and atherosclerosis in middle age: a population-based cohort study
Á Herraiz-Adillo, VH Ahlqvist… - British journal of sports …, 2024 - bjsm.bmj.com
Objectives To examine the associations between physical fitness in male adolescents and
coronary and carotid atherosclerosis in middle age. Methods This population-based cohort …
coronary and carotid atherosclerosis in middle age. Methods This population-based cohort …
Update of the Brazilian guideline for familial hypercholesterolemia–2021
MCO Izar, VZR Giraldez, A Bertolami… - Arquivos brasileiros de …, 2021 - SciELO Brasil
Financial declaration A-Economically relevant payments of any kind made to (i) you,(ii) your
spouse/partner or any other person living with you,(iii) any legal person in which any of …
spouse/partner or any other person living with you,(iii) any legal person in which any of …
Prognostic value of coronary calcium score in asymptomatic individuals: a systematic review
L Tramontano, B Punzo, A Clemente, S Seitun… - Journal of Clinical …, 2022 - mdpi.com
Despite updated guidelines and technological developments that allow for an accurate
diagnosis, many asymptomatic individuals have a high risk of developing CAD or cardiac …
diagnosis, many asymptomatic individuals have a high risk of developing CAD or cardiac …
Does coronary calcium score zero reliably rule out coronary artery disease in low-to-intermediate risk patients? A coronary CTA study
Background Objective was to assess if coronary calcium score (CCS) zero (< 1.0 AU)
reliably rules out coronary artery disease (CAD) by coronary CTA; and if a difference …
reliably rules out coronary artery disease (CAD) by coronary CTA; and if a difference …
Prognostic value of stress CMR in symptomatic patients with coronary stenosis on CCTA
T Pezel, T Hovasse, T Lefèvre, F Sanguineti… - Cardiovascular …, 2022 - jacc.org
Background Noninvasive functional imaging is often performed in patients with obstructive
coronary artery disease (CAD) on coronary computed tomography angiography (CTA) …
coronary artery disease (CAD) on coronary computed tomography angiography (CTA) …
[HTML][HTML] Atualização da Diretriz Brasileira de Hipercolesterolemia Familiar–2021
MCO Izar, VZR Giraldez, A Bertolami… - Arquivos Brasileiros …, 2021 - SciELO Brasil
Atualização da Diretriz Brasileira de Hipercolesterolemia Familiar–2021 O relatório abaixo
lista as declarações de interesse conforme relatadas à SBC pelos especialistas durante o …
lista as declarações de interesse conforme relatadas à SBC pelos especialistas durante o …
Updates on the use of subclinical atherosclerosis to predict risk of cardiovascular events in heterozygous familial hypercholesterolemia
Abstract Purpose of Review The high variability of cardiovascular risk in heterozygous
familial hypercholesterolemia (HeFH) is a challenge for therapeutical management …
familial hypercholesterolemia (HeFH) is a challenge for therapeutical management …